Fig. 1. Kaplan-Meier analysis of relapse-free survival (RFS) and disease-specific survival (DSS) in all breast cancer patients. (A) RFS according to age at diagnosis, (B) DSS according to age at diagnosis, (C) RFS according to molecular subtypes, and (D) DSS according to molecular subtypes. HER2, human epidermal growth factor receptor 2; TNBC, triple-negative breast cancer.
